Discover the course

Data Transparency: Its Impact on Clinical Trials

Effectively facing with the new environment of clinical studies


14 - 15 September 2020





Data Transparency: Its Impact on Clinical Trials

Data transparency in clinical trials has become an essential requirement for anyone involved in clinical studies.
Although many pharmaceutical companies had spontaneously provided the opportunity to access data collected during their clinical trials to anyone who requested it, policy 0070 of the European regulatory agency (EMA), section 801 of the Food and Drug Administration’s Act (FDAAA), the initiative Restoring Invisible and Abandoned Trials (RIAT), the requests by the International Committee of Medical Journal Editors (ICMJE) and the European regulation on clinical studies (536/2014), have made mandatory the effective management and publication of the data collected in clinical trials. The policy 0070 “on publication of clinical data for medicinal products for human use” has made the publication of the main documents sustaining the registration dossier of new products mandatory; its final goal is making publicly available the data collected during each clinical trial which was used for registration purposes.
An analogous approach is the one followed by the FDA, other regulatory authorities, the ICMJE and the main medical-scientific congresses that require, together with the publications that report the results of each clinical trial, also the protocol, patient’s level data, and the methods used for their analysis. This new approach makes mandatory to redefine both the management of company’s confidential data and patient’s personal by the clinical study sponsor. A challenge to be effectively faced for its translation to communication effectiveness.
This course aims to provide practical tools to manage the new clinical trial environment in a proactive and effective way.

Opening remarks

Collection of expectations

Individual questionnaire compilation

The principles of clinical research

Public reputation of pharmaceutical companies

Patient’s requests

  • The informed consent
  • All trials

Analysis of the individual questionnaire and discussion


The requests of the International Committee of Medical Journal Editors (ICMJE)

Registration of study protocols

  • Clinical studies registries
  • Publication of clinical trials results
  • Non-interventional studies

The regulations on the publication of the results of clinical trials through the world and their implications

Data sharing initiatives

  • PhRMA
  • The RIAT

The EMA approach

  • EMA Policy 0070

 The FDA approaches

  • Section 801 of the FDAAA

Clinical study reports and clinical investigation reports


Confidential data

Individual patient’s data

The statistical implications

  • The SAP

The companies' point of view

How information is published

Establish Strategic Timelines for Publications Development and Publishing

Practical exercise

  • Understand Quantified Risk Assessments
  • Create Data Anonymisation Strategies
  • Manage the EMA Timeline

Verification of expectations and conclusions

Andrea Rossi
Andrea Rossi Freelance International Scientific Communicator

Andrea has a degree in Biology from Florence University. After a brief spell at the University, he started working in the Italian Affiliate of Eli Lilly as a Clinical Research Associate. In the years that followed he was responsible for Statistics, Health Outcomes and Medical Information. Andrea has been working as Medical Writer since 2003 beginning in Italy and, then, becoming responsible of worldwide scientific affairs in a biosimilar company based in Switzerland.
He is author of more than 350 disclosures and acknowledged for his contribution in several others. From 2007 to 2009 he was on the coordination board of BIAS (Biometristi Italiani Associati) and has been a European Medical Writers Association (EMWA) member since 2004. Andrea acts as trainer for statistics and medical writing in some Italian schools for specialisation in medicine and has been a speaker at national and international conferences.
Andrea leads workshops for and is past-president and ambassador of EMWA.

All company figures involved in the development, registration and reporting of clinical trials on products for medical use including:

  • Clinical Operations
  • Regulatory
  • Medical Affairs
  • Clinical data registration
  • Statistics
  • Scientific Communications
  • Medical Information
  • Clinical Information
  • Marketing
  • Compliance
  • Quality assurance
  • Pharmacology
  • CRM
  • Transparency
  • Legal
  • Data management
  • Real World Data

Participant experience

Participants should be aware of the basic principles governing clinical trials and the regulations to be used for the approval of new medical products in Europe.

Interactive workshop with on-train exercises and application to participant’s daily activities.

The training course will take place in Berlin.

Upon Arrival
At your arrival you will find our Staff at the Welcome Desk to greet and make you feel welcome and as comfortable as possible, providing direction and all information about the meeting, seating, refreshments.

Coffee breaks and lunch will provide a pleasant moment of refreshment. Special care about the food quality, in particular to your dietary needs or preferences, from menus of local products and flavors to vegetarian dishes.

Limited number of participants to encourage networking and discussion.

Training Room

All our training facilities are safe, healthy, comfortable, aesthetically-pleasing, and accessible. They are able to accommodate the specific space and equipment needs of the training program.
Depending on the seating configuration, the room may accommodate lecture-style instruction or encourage interaction in the form of roundtable discussions. Equipped for audio/visual, Free Wi-Fi to allow everyone to connect with just one click, electric sockets.

Teaching materials

All the information necessary for learning during the course is provided. It is recommended to bring your PC to take notes (even directly on the slides provided in PDF format). The environment is important to us and that's why we try to make this meeting an experience of environmental sustainability.

Fee includes
Tuition, teaching materials, lunch and coffee breaks, organizational office assistance, attendance certificate. 

The course will proceed with a minimum number of participants. Should this number not be reached the registered participants will be notified one week prior to the commencement of the course.
Certificate of attendance

Early Bird: € 1.570,00* (until 17 August 2020)

Ordinary: € 1.780,00*

Freelance - Academy - Public Administration**: € 890,00*

for Italian companies: +22% VAT

**Early Bird discount not applicable to Freelance – Academy – Public Administration fee

The fee includes: tuitions, teaching materials, lunches and coffee breaks, organizational office assistance, attendance certificate.

Register now

Course Price

1780.00 €

Early Bird

Monday, August 17, 2020

1570.00 €

Payments accepted

  • Bank Transfer
  • Credit Card
  • PayPal

Other Details


2 days

Course Type

Limited number of partecipants

You will receive

Certificate of attendance

At the end of the training, you will be able to

  • Manage the principles of clinical data sharing

  • Evaluate the implications for ensuring resources needed to effectively and efficiently address data transparency needs

  • Transform new legislative requirements into an opportunity to improve image and company’s productivity

Participants' Feedbacks

The venue is very beautiful and LS Academy staff was efficient

You may also be interested in

Close Menu


Data Transparency: Its Impact on Clinical Trials

information request

Terms & Conditions

The fee includes: tuition, teaching materials, lunches and coffee breaks, organizational office assistance, attendance certificate. Early Bird discount not applicable to Freelance – Academy – Public Administration fee.
The course will proceed with a minimum of 8 participants. Should this number not be reached the registered participants will be notified one week prior to the commencement of the course.
For further information please contact:  e-mail:  telephone: +39 (0)35.515684

The fee includes: seat at the conference, copy of presentations of Speakers who allow the distribution, informative literature for the day, networking lunch, coffee break, organisational office assistance, certificate of attendance. For further information please contact:  e-mail:  telephone: +39 (0)35.515684

Common Terms & Conditions

Terms of payment
Payment should be made online (by credit card) or by bank transfer, at the time of registration (only for Italian companies: + 22% VAT) to EasyB s.r.l by bank transfer or by credit card. Bank transfer payable to:

EasyB S.r.l.
Via Roma, 20 – 24022 Alzano Lombardo (Bergamo)
VAT: IT03633040161
BANCO BPM – Filiale di Carobbio degli Angeli
IBAN: IT81 F 05034 53960 000000003450

Confirmation of event admission will be given on receipt of payment. Invoice will be sent following receipt of payment. EasyB reserves the right to refuse late registrations or additional registrations above the maximum accepted number of participants or registrations of roles that are not included in the target of the event.

Please note that refunds (70% refund of the registration fee) will only be given if cancellation is received at least one week before the event date. Cancellations will only be valid if made in writing. Transfer of registrations (or name changes) are allowed and should be made in writing within 7 days prior to the event. EasyB reserves the right to postpone or cancel an event, to change the location of an event or to alter the advertised speakers for an event. EasyB is not responsible for any loss or damage as a result of substitution, alteration, postponement or cancellation of an event due to causes beyond its control including without limitation, acts of God, natural disasters, sabotage, accident, trade of industrial disputes, terrorism, or hostilities.

Information collection and use
In accordance with the Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016, we inform you that EasyB S.r.l. (with headquarter in Via Roma 20, Alzano Lombardo, Bergamo, Italy, VAT number IT03633040161) will use your personal data voluntarily provided by you only with the consent and in compliance with the principles dictated by the European Regulations on the protection of personal data for sending newsletters, for marketing purposes (sending advertising material, market research and commercial communication) and for communication purposes to third parties (lecturers, scientific board, speakers, conferences’ sponsor), also for marketing goals. You can read the complete information, including your rights and the procedures for the exercise of the same, 
following this link.